Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma
Targeted nanoparticle (NP) delivery vehicles are emerging technologies, the full potential of which has yet to be realized. Sulfatide is known to bind to extracellular matrix glycoproteins that are highly expressed in breast tumors. In this study, we report for the first time the combination of sulf...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145830/ |